Material supplied by VTNA may be used for educational analysis or research only. Any editing, reproduction, publication, rebroadcast, public showing or public display may be prohibited by copyright laws.
(Studio: John Roberts) A petition to the FDA to pull the arthritis drugs Celebrex & Bextra from the market noted.
(Washington: Sharyl Attkisson) Concern over whether Pfizer’s Celebrex is best for people with gastro-intestinal problems who have trouble with over-the-counter pain relievers examined; results of a 2000 "Journal of the American Medical Assn." study cited. [Pfizer consultant/researcher Dr. David BORENSTEIN- says the drugs were developed because they were easier on the stomach.] [Harvard Medical School Dr. John ABRAMSON- notes people in the 2nd half of the Celebrex study had more stomach problems.] [Celebrex patient Auli PETERSON- says she would like to continue Celebrex.]
- Roberts, John;
- Attkisson, Sharyl
Note to sponsor members: The Vanderbilt Television News Archive video player requires a modern operating system and browser to work properly. If you are experiencing playback problems, check the minimum requirements and adjust your setup accordingly. After adjustments, if you continue to experience problems, please contact us.
Welcome! Above is the abstract of the item that you're interested in viewing from the Vanderbilt Television News Archive's collection. You have three options if you'd like to view this item:
- You may request a loan of this video by registering on our website and placing an order.
- You may visit the Television News Archive on the Vanderbilt campus to view on-site from the Archive's collection.
- If you are associated with a college or university, you may ask your library if they would like to become a sponsor, which would give students and faculty at your institution the ability to view items from our collection.
If you believe that you are associated with a sponsoring college or university and have received this message in error, please let us know.